Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset

Journal of Rheumatology

Volumn 29, Issue 2, 2002, Pages 271-275

  González Gay, Miguel A ^a   Hajeer, Ali H ^a   García Porrúa, Carlos ^a   Dababneh, Adele ^a   Thomson, Wendy ^a   Ollier, William E R ^a   Mattey, Derek L ^a  

^a Staffordshire Rheumatology Centre   (United Kingdom)

Author keywords

Cyclosporine; Disease severity; Rheumatoid arthritis; Shared epitope

Indexed keywords

CHLOROQUINE; CYCLOSPORIN; EPITOPE; HLA DR ANTIGEN; METHOTREXATE;

ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT INDICATION;

ADULT; AGE OF ONSET; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; COHORT STUDIES; CYCLOSPORINE; DNA; DRUG THERAPY, COMBINATION; EPITOPES; FEMALE; GENE FREQUENCY; HISTOCOMPATIBILITY TESTING; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JOINTS; MALE; MIDDLE AGED; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 0036163549     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis
2. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein in patients with rheumatoid arthritis receiving methotrexate
3. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis
4. Combination therapy of cyclosporine with methotrexate and gold in rheumatoid arthritis (2 pilot studies)
5. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: An open-label extension study
6. Divergent effect of cyclosporine on Th1/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis
7. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
8. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis
9. Association of the shared epitope with radiological severity of rheumatoid arthritis
10. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis
11. HLA-DRB1 alleles associated with susceptibility or resistance to rheumatoid arthritis, articular deformities, and disability in Mexican Americans
12. HLA-DRB1 alleles and shared amino acid sequences in disease susceptibility and severity in patients from eastern France with rheumatoid arthritis
13. HLA-DRB1 genotype influences risk for severity of rheumatoid arthritis
14. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis: Results of a follow-up study
15. Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients
16. HLA-DRB1 and DQB typing of Hispanic American patients with rheumatoid arthritis: The "shared epitope" hypothesis may not apply
17. Lack of association of HLA-DRB1 genotype with radiologic progression in Japanese patients with early rheumatoid arthritis
18. The predictive value of the HLA shared epitope for severity of radiological joint damage in patients with rheumatoid arthritis. A 10 year observational prospective study
19. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
20. Combined therapy with cyclosporine and methotrexate: Long-term follow up
21. The use of cyclosporin A microemulsion in rheumatoid arthritis: Conclusions of an international review
22. Radiographic evaluation of radiologic progression in rheumatoid arthritis and related conditions by standard reference films
23. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients
24. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis
25. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: Increased association in men, young age at onset and disease severity
26. Compound heterozygosity for the shared epitope and the risk and severity of rheumatoid arthritis in extended pedigrees
27. Tumor necrosis factor α microsatellite polymorphism is associated with rheumatoid arthritis severity through an interaction with the HLA-DRB1 shared epitope
28. Interaction between tumor necrosis factor microsatellite polymorphisms and the HLA-DRB1 shared epitope in rheumatoid arthritis. Influence on disease outcome